Davidson & Garrard’s Amgen AMGN Stock Holding History

Davidson & Garrard’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$731K	Sell	3,920 -1,135	-22%	-$201K	0.17%	114
2017 Q2	$871K	Hold	5,055	–	–	0.21%	106
2017 Q1	$829K	Buy	5,055 +128	+3%	+$21.3K	0.2%	111
2016 Q4	$720K	Buy	4,927 +63	+1%	+$9.48K	0.18%	114
2016 Q3	$811K	Hold	4,864	–	–	0.2%	110
2016 Q2	$740K	Hold	4,864	–	–	0.18%	115
2016 Q1	$729K	Hold	4,864	–	–	0.19%	115
2015 Q4	$790K	Sell	4,864 -138	-3%	-$21.7K	0.2%	118
2015 Q3	$692K	Sell	5,002 -82	-2%	-$12.9K	0.18%	124
2015 Q2	$780K	Hold	5,084	–	–	0.18%	125
2015 Q1	$813K	Sell	5,084 -175	-3%	-$27.6K	0.19%	122
2014 Q4	$838K	Hold	5,259	–	–	0.19%	120
2014 Q3	$739K	Sell	5,259 -49	-0.9%	-$6.4K	0.18%	123
2014 Q2	$628K	Sell	5,308 -50	-0.9%	-$5.79K	0.15%	127
2014 Q1	$661K	Sell	5,358 -25	-0.5%	-$3.03K	0.16%	124
2013 Q4	$614K	Sell	5,383 -150	-3%	-$17.1K	0.16%	127
2013 Q3	$619K	Sell	5,533 -800	-13%	-$86.7K	0.17%	118
2013 Q2	$625K	Buy	+6,333	New	+$657K	0.19%	108

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Davidson & Garrard's AMGN Position: Q3 2017 in Review

Davidson & Garrard reduced its Amgen (AMGN) stake by 22% in Q3 2017, selling an estimated $201K and leaving 3,920 shares worth $731K. The position accounts for 0.17% of the portfolio, ranked #114.

Davidson & Garrard first reported a position in AMGN in Q2 2013 and has held it in 18 quarters since. The position peaked at $871K in Q2 2017. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

Davidson & Garrard held 3,920 shares of Amgen worth $731K as of Q3 2017.
Davidson & Garrard sold 1,135 Amgen shares in Q3 2017, an estimated $201K.
Amgen made up 0.17% of Davidson & Garrard's portfolio in Q3 2017, its #114 holding.
Davidson & Garrard first reported a position in Amgen in Q2 2013 and has held it in 18 quarters since.
Davidson & Garrard's Amgen position peaked at $871K in Q2 2017.
1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.